Information Provided By:
Fly News Breaks for July 10, 2015
NEO
Jul 10, 2015 | 07:04 EDT
William Blair says the Centers for Medicare & Medicaid Services' preliminary ruling for the 2016 Physician Fee Schedule published Wednesday included "very favorable" increases for tests performed by NeoGenomics. The Medicare increase should enable NeoGenomics to argue for higher reimbursement from all payers, the firm tells investors in a research note. It keeps an Outperform rating on NeoGenomics after the stock rallied 25% yesterday to $6.47.
News For NEO From the Last 2 Days
There are no results for your query NEO